Date/Time
Date(s) - October 6, 2022
12:00 pm - 1:00 pm
Learn more about: Second-line (2L) standard-of-care (SOC) for large B-cell lymphoma (LBCL) CD19 CAR-T for relapsed/refractory (R/R) LBCL (>2L) Impact of the CD19 CAR product on outcomes of R/R LBCL CD19 CAR-T versus SOC for 2L high-risk LBCL
Speaker: Jordan Gauthier, MD, MSC
University of Washington School of Medicine
This is an online event. Please RSVP
https://usc.zoom.us/meeting/register/tJckfuuvqzIpHtDz30 KDsDat3_Bsoanx4sLO